These are good questions to ask because for the most part we've been having mgmt pr small highlights and cherry pick data that sounds amazing. Im not saying it isn't, but having the whole story would be nice.

I think one plausible explanation for no big pharma offer is amarex data is what they saw. If there are missing elements and scatterbrained entries do you trust the data if you're big pharma or do you think the company is hiding something?

Luckily we've moved on from them and hopefully have legit cros for nash and creativ tech for cancer. Good clean data could make all the difference. If Dr. Recknor was able to call out the amarex mess, you can be sure other big pharma people were able to do the same.

I'm not saying this is in fact what happened, but wouldn't be surprised if it was.